Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

By Kupelian P.   Katcher J.   Levin H.   Zippe C.   Klein E.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 249-260

Elsevier

Access to resources Recommend Favorite

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

By Ung J.O.   Richie J.P.   Chen M.-H.   Renshaw A.A.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 458-463

Elsevier

Access to resources Recommend Favorite

Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer?

By Servoll Einar   Sæter Thorstein   Vlatkovic Ljiljana   Nesland Jahn   Waaler Gudmund   Beisland Hans Olav  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 4, 2010-09 ,pp. : 217-222

Informa Healthcare

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Radical Prostatectomy and Iodine 125 Interstitial Radiotherapy for the Treatment of Clinically Localized Prostate Cancer: A 7-Year Biochemical (PSA) Progression Analysis - a case-controlled comparison of conservative treatment versus ra

By Polascik T.J.   Pound C.R.   DeWeese T.L.   Walsh P.C.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 884-890

Elsevier

Access to resources Recommend Favorite